NDC 71872-7324-01 - Cleocin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7324
- Requested NDC
- 71872-7324-01
- Package NDCs from labels
- 71872-7324-1, 71872-7324-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2024-03-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleocin Phosphate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2024-03-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7324-1 | Cleocin Phosphate | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 1 | |
| 71872-7324-1 | Cleocin Phosphate | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7324 | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 1 | Current NDC, 2 package rows | 20240307_12ee0720-9979-3162-e063-6394a90a8003.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cleocin Phosphate | CLINDAMYCIN PHOSPHATE | ProPharma Distribution | 38416189-844b-939f-e063-6394a90aa271 | 2025-07-18 | Boxed warning, Warnings, Adverse reactions | NDA050441 1737578 1737579 EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | NORTHSTAR RX LLC | f8c7339a-5180-4c6a-99bf-8a7e4d94f2d2 | 2025-07-09 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | b39aaacb-f429-4cb4-b88b-341b8b8b217c | 2025-07-03 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | 0a98fc1e-be75-4c22-a7a7-2e4f033b3701 | 2025-07-03 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Sun Pharmaceutical Industries, Inc. | 20333796-e2b9-4e11-860b-1dc5ff038b03 | 2025-07-03 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Sun Pharmaceutical Industries, Inc. | 449884c1-cf3b-4e2c-b8a0-82442ea8523a | 2025-07-03 | Warnings, Adverse reactions | EH6D7113I8 |
| Cabtreo | CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE | Bausch Health US LLC | 9468da0f-9978-4c58-8135-0274c3415084 | 2025-04-24 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Alembic Pharmaceuticals Limited | 41ab7061-7c3a-4a4c-9c44-16851c97ad00 | 2025-03-03 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Mayne Pharma | c7381600-2e4c-4e7b-aa67-fe7d5fae7b40 | 2025-02-28 | Warnings, Adverse reactions | EH6D7113I8 |
| CLEOCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Henry Schein, Inc. | 184acaee-6129-479e-850f-d89575b8b391 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | NDA050441 1737244 1737245 EH6D7113I8 |
| Clindesse | CLINDAMYCIN PHOSPHATE | Padagis Israel Pharmaceuticals Ltd | fe8bb204-f173-44fe-803b-b08f2ec5aa31 | 2025-01-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Solaris Pharma Corporation | b46941a9-e75f-48f7-b426-03f307499713 | 2025-01-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Tretinoin | CLINDAMYCIN PHOSPHATE AND TRETINOIN | Solaris Pharma Corporation | c3ad6c2d-d106-464d-8e27-67ae94793e88 | 2025-01-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Zydus Lifesciences Limited | cc45f9bc-4639-4d95-b12d-01f6504592bb | 2024-11-26 | EH6D7113I8 | |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bryant Ranch Prepack | db39492e-d964-4e59-8d65-0a2194e9a3d4 | 2024-11-11 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Oceanside Pharmaceuticals | 7fd5e0a2-159b-4147-947e-944eeebc1783 | 2024-11-11 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Northstar Rx LLC | 2fcf4e8d-dd05-49c2-948b-10abbb52e4bc | 2024-11-08 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phoaphate Topical Solution USP, 1% | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1% | Northstar Rx LLC | 407f6d80-7de0-45d9-8ad2-5b95d233b96d | 2024-11-08 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE | Bryant Ranch Prepack | 4e09c0e6-7da1-462c-9f1f-64c18e5f58f9 | 2024-10-18 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Solaris Pharma Corporation | fde07866-b012-47ad-932e-b76f141f86ee | 2024-09-13 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.